Formulation and evaluation of mucoadhesive glipizide films

S. Baumgartner and J. Kristl, Optimisation of floating matrix tablets and evaluation of their gastric residence time, Int. J. Pharm. 195 (2000) 125-135; DOI: 10.1016/S0378-5173(02)00022-4.10.1016/S0378-5173(02)00022-4Search in Google Scholar

A. Streubel, J. Siepmann and R. Bodmeier, Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci. 18 (2003) 37-45; DOI: 10.1016/S0928-0987(02)00223-3.10.1016/S0928-0987(02)00223-3Search in Google Scholar

J. K. Patel and J. R. Chavda, Formulation and evaluation of stomach specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy, J. Microencap. 26 (2009) 305-376; DOI: 10.1080/02652040802373012.10.1080/02652040802373012Search in Google Scholar

H. R. Chueh, H. Zia and C. T. Rhodes, Optimization of sotalol and bioadhesive extended-release tablet formulations, Drug Dev. Ind. Pharm. 21 (1995) 1725-1747; DOI: 10.3109/03639049102946315.Search in Google Scholar

B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Release 63 (2000) 235-259; DOI: 10.1016/S0168-3659(99)00204-7.10.1016/S0168-3659(99)00204-7Search in Google Scholar

W. A. Ritschel, Targeting in the gastrointestinal tract: New approaches, Methods Find. Exp. Clin. Pharmacol. 13 (1991) 313-316.Search in Google Scholar

S. Li, S. Lin and B. P. Daggy, Effect of formulation variables on the floating properties of gastric floating drug delivery system, Drug Dev. Ind. Pharm. 28 (2002) 783-793; DOI: 10.3109/03639049109057315.10.3109/03639049109057315Search in Google Scholar

J. K. Patel, R. Patel, A. F. Amin and M. Patel, Formulation and evaluation of mucoadhesive glipizide microspheres, AAPS PharmSciTech. 6 (2005) 49-55; DOI: 10.1208/pt060110.10.1208/pt060110Search in Google Scholar

R. Foster and G. Plosker, Glipizide: A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus, Pharmacoeconomics 18 (2000) 289-306.Search in Google Scholar

A. G. Thombre, A. R. Denoto and D. C. Gibbes, Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients, J. Control. Release 60 (1999) 333-341; DOI: 10.1023/A:1011945625750.Search in Google Scholar

S. Garg, K. Vermani, A. Garg, R. A. Anderson, B. W. Rencher and L. J. D. Zaneveld, Development and characterization of bioadhesive vaginal films of sodium polystyrene sufonate (PSS), a novel contraceptive antimicrobial agent, Pharm. Res. 22 (2005) 584-595.10.1007/s11095-005-2490-1Search in Google Scholar

R. C. Mashru, V. B. Sutariya, M. G. Sankalia and P. P. Parikh, Development and evaluation of fast-dissolving film of salbutamol sulphate, Drug Dev. Ind. Pharm. 1 (2005) 25-34; DOI: 10.3109/03612489109057315.Search in Google Scholar

M. A. Alam, F. J. Ahmad, Z. I. Khan, R. K. Khar and M. Ali, Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections, AAPS PharmSciTech. 8 (2007) E 1-8; DOI: 10.1208/pt0804109.10.1208/pt0804109Search in Google Scholar

The United States Pharmacopeia/The National Formulary, 24th ed., USA Convention, Inc., Rockville 1999, pp. 2076-2078.Search in Google Scholar

A. Dokoumetzidis, V. Papadopoulou, P. Macheras, Analysis of dissolution dara using modified versions of Noyes-Whitney equation and the Weibull function, Pharm. Res. 23 (2006) 256-261.Search in Google Scholar

R. Korsemeyer, R. Gurny and N. Peppas, Mechanisms of solute release from porous hydrophylic polymers, Int. J. Pharm. 15 (1983) 25-35.10.1016/0378-5173(83)90064-9Search in Google Scholar

C. R. Kahn, Y. Shechter, W. R. Theodore, S. N. Alan, P. Taylor and A. G. Gilman (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8^th ed., McGraw-Hill, New York 1991, p. 1712.Search in Google Scholar

M. Berelowitz, C. Fischette, W. Cefelu and D. S. Schade, Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM, Diabetes Care 17 (1994) 1460-1464.10.2337/diacare.17.12.14607882817Search in Google Scholar